PL2182948T3 - Zastosowanie imidazochinolin do leczenia chorób EGFR-zależnych albo chorób wykazujących nabytą oporność wobec środków ukierunkowanych na członków rodziny EGFR - Google Patents
Zastosowanie imidazochinolin do leczenia chorób EGFR-zależnych albo chorób wykazujących nabytą oporność wobec środków ukierunkowanych na członków rodziny EGFRInfo
- Publication number
- PL2182948T3 PL2182948T3 PL08786340T PL08786340T PL2182948T3 PL 2182948 T3 PL2182948 T3 PL 2182948T3 PL 08786340 T PL08786340 T PL 08786340T PL 08786340 T PL08786340 T PL 08786340T PL 2182948 T3 PL2182948 T3 PL 2182948T3
- Authority
- PL
- Poland
- Prior art keywords
- diseases
- egfr
- imidazoquinolines
- agents
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07112998 | 2007-07-24 | ||
| PCT/EP2008/059642 WO2009013305A1 (en) | 2007-07-24 | 2008-07-23 | Use of imidazoquinolines for the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family members |
| EP08786340A EP2182948B1 (en) | 2007-07-24 | 2008-07-23 | Use of imidazoquinolines for the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family members |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2182948T3 true PL2182948T3 (pl) | 2013-07-31 |
Family
ID=38779856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL08786340T PL2182948T3 (pl) | 2007-07-24 | 2008-07-23 | Zastosowanie imidazochinolin do leczenia chorób EGFR-zależnych albo chorób wykazujących nabytą oporność wobec środków ukierunkowanych na członków rodziny EGFR |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20100196365A1 (pl) |
| EP (1) | EP2182948B1 (pl) |
| JP (1) | JP2010534219A (pl) |
| KR (1) | KR20100039354A (pl) |
| CN (1) | CN103298471A (pl) |
| AU (1) | AU2008280105B2 (pl) |
| BR (1) | BRPI0814346A2 (pl) |
| CA (1) | CA2693799A1 (pl) |
| ES (1) | ES2401822T3 (pl) |
| PL (1) | PL2182948T3 (pl) |
| PT (1) | PT2182948E (pl) |
| RU (2) | RU2481838C2 (pl) |
| WO (1) | WO2009013305A1 (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009109605A1 (en) * | 2008-03-05 | 2009-09-11 | Novartis Ag | Use of pyrimidine derivatives for the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family members |
| US8476294B2 (en) * | 2009-06-04 | 2013-07-02 | Novartis Ag | 1H-imidazo[4,5-c]quinolinone derivatives |
| MX2014004559A (es) * | 2011-10-14 | 2014-08-01 | Novartis Ag | Derivados de 2-carboxamida cicloamino urea en combinacion con inhibidores de hsp90 para el tratamiento de enfermedades proliferativas. |
| TW201703769A (zh) * | 2015-05-08 | 2017-02-01 | 美國禮來大藥廠 | 用於癌症的組合療法 |
| WO2016185443A1 (en) | 2015-05-20 | 2016-11-24 | Novartis Ag | Pharmaceutical combination of everolimus with dactolisib |
| MX2019006090A (es) | 2016-11-23 | 2019-08-21 | Novartis Ag | Metodos para mejorar la respuesta inmune con everolimus, dactolisib o ambos. |
| WO2019157516A1 (en) | 2018-02-12 | 2019-08-15 | resTORbio, Inc. | Combination therapies |
| CN110812479A (zh) * | 2019-11-18 | 2020-02-21 | 青海晨菲制药有限公司 | 没食子酸和egfr靶点抗体组合物及其在肺癌上应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR046845A1 (es) * | 2003-11-21 | 2005-12-28 | Novartis Ag | Derivados de 1h-imidazo[4,5-c]quinolina para tratamiento de enfermedades dependientes de las proteino-quinasas |
| KR20160096228A (ko) * | 2004-07-22 | 2016-08-12 | 제넨테크, 인크. | Ｈｅｒ２ 항체 조성물 |
| GB0510390D0 (en) * | 2005-05-20 | 2005-06-29 | Novartis Ag | Organic compounds |
| WO2009109605A1 (en) * | 2008-03-05 | 2009-09-11 | Novartis Ag | Use of pyrimidine derivatives for the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family members |
-
2008
- 2008-07-23 EP EP08786340A patent/EP2182948B1/en not_active Not-in-force
- 2008-07-23 PL PL08786340T patent/PL2182948T3/pl unknown
- 2008-07-23 PT PT87863403T patent/PT2182948E/pt unknown
- 2008-07-23 AU AU2008280105A patent/AU2008280105B2/en not_active Ceased
- 2008-07-23 BR BRPI0814346-3A2A patent/BRPI0814346A2/pt not_active IP Right Cessation
- 2008-07-23 CN CN2008800255319A patent/CN103298471A/zh active Pending
- 2008-07-23 US US12/668,083 patent/US20100196365A1/en not_active Abandoned
- 2008-07-23 ES ES08786340T patent/ES2401822T3/es active Active
- 2008-07-23 WO PCT/EP2008/059642 patent/WO2009013305A1/en active Application Filing
- 2008-07-23 CA CA2693799A patent/CA2693799A1/en not_active Abandoned
- 2008-07-23 KR KR1020107001624A patent/KR20100039354A/ko not_active Application Discontinuation
- 2008-07-23 JP JP2010517392A patent/JP2010534219A/ja active Pending
- 2008-07-23 RU RU2010106241/15A patent/RU2481838C2/ru not_active IP Right Cessation
-
2012
- 2012-12-04 RU RU2012151889/15A patent/RU2012151889A/ru not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2008280105A1 (en) | 2009-01-29 |
| ES2401822T3 (es) | 2013-04-24 |
| EP2182948B1 (en) | 2013-03-06 |
| RU2481838C2 (ru) | 2013-05-20 |
| WO2009013305A1 (en) | 2009-01-29 |
| AU2008280105B2 (en) | 2011-10-20 |
| CA2693799A1 (en) | 2009-01-29 |
| JP2010534219A (ja) | 2010-11-04 |
| RU2012151889A (ru) | 2014-06-10 |
| KR20100039354A (ko) | 2010-04-15 |
| BRPI0814346A2 (pt) | 2015-01-20 |
| EP2182948A1 (en) | 2010-05-12 |
| RU2010106241A (ru) | 2011-08-27 |
| US20100196365A1 (en) | 2010-08-05 |
| CN103298471A (zh) | 2013-09-11 |
| PT2182948E (pt) | 2013-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2125855A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER OR OTHER DISEASES | |
| ZA200906210B (en) | 3-Imidazolyl-Indoles for the treatment of proliferative diseases | |
| HK1138850A1 (en) | Quinoline derivatives for the treatment of inflammatory diseases | |
| BRPI0908026A2 (pt) | Métodos para o tratamento de doenças do intestino | |
| AP2960A (en) | Substituted pyrimidines for the treatment of diseases such as cancer | |
| PL3208612T3 (pl) | Kompozycje i sposoby leczenia chorób o podłożu immunologicznym | |
| ES2525801T8 (es) | Composiciones y métodos para la prevención y el tratamiento de enfermedades autoinmunes | |
| ZA200707591B (en) | Dihyrothienopyrimidines for the treatment of inflammatory diseases | |
| PL2182948T3 (pl) | Zastosowanie imidazochinolin do leczenia chorób EGFR-zależnych albo chorób wykazujących nabytą oporność wobec środków ukierunkowanych na członków rodziny EGFR | |
| IL225519A0 (en) | Effective preparations and methods for the treatment and diagnosis of inflammatory bowel disease | |
| EP2210092A4 (en) | SEMAPHORINE COMPREHENSIVE COMPOSITIONS FOR THE TREATMENT OF DISEASES RELATED TO ANGIOGENESIS AND SELECTION PROCEDURES THEREFOR | |
| IL226473A0 (en) | Compounds@פירימידינון@לוחשות@בפיפול@בפילות@או@מעבוןים@המתוחים@על@ידי@@lp–pla | |
| IL216967B (en) | The history of 17-hydroxy-17-pentafluoroethyl-astra-9,4 (10)-diene-11-aryl and their use for the treatment of diseases | |
| IL212057A0 (en) | Compositions for the treatment of bowel diseases with granulated mesalamine | |
| HK1141447A1 (en) | Pharmaceutical composition for the treatment of proliferative diseases | |
| IL200091A0 (en) | Use of chitosans for the treatment of nail inflammatory diseases | |
| IL201449A0 (en) | Heteroarylamide-substituted pyrimidone derivatives for the treatment of neurodegenerative diseases | |
| GB0700972D0 (en) | Treatment of inflammatory disease | |
| IL201562A0 (en) | Arylamide pyrimidone derivatives for the treatment of neurodegenerative diseases | |
| FI20095600A (fi) | Koostumus ihosairauksien hoitoa varten | |
| IL213703A (en) | Compounds for the treatment of pain and other diseases | |
| PL2234631T3 (pl) | Związki i metody stosowane w terapii choroby naczyniowej | |
| EP2258374A4 (en) | USE OF MASLINIC ACID FOR THE TREATMENT OF DISEASES AND THEIR SYMPTOMS THROUGH COX-2 INHIBITION | |
| EP2170351A4 (en) | METHOD AND COMPOSITION FOR TREATING CANCER AND OTHER ANGIOGENESIS-MEDIATED ILLNESSES | |
| GB0720976D0 (en) | Treatment of inflammatory disease |